Properties of the tetrodotoxin binding component in plasma membranes isolated from Electrophorus electricus

Biochemistry
J K Reed, M A Raftery

Abstract

The biochemical properties of the electrically excitable sodium channels in the electroplaque of Electrophorus electricus were investigated using tritiated tetrodotoxin (TTX) as a specific membrane probe. Membrane fragments from the electroplaque were isolated essentially by differential centrifugation and characterized with respect to the plasma membrane markers acetylcholine receptors, acetylcholinesterase, (Na+ + K+)ATPase, and [3H]TTX binding. Equilibrium binding studies showed that [3H]TTX bound to a single population of noninteracting receptor sites with an apparent dissociation constant of 6 +/- 1 X 10(-9) M. The toxin-membrane complex dissociated with a first-order rate constant of 0.012 sec-1. Studies on the pH dependence of complex formation demonstrated the requirement for an ionizable, functional group with a pK of 5.3 and this group has been shown to be a carboxyl. Treatment of the membranes with trimethyloxonium tetrafluoroborate, a carboxyl group modifying reagent, resulted in an irreversible loss in the binding of [3H]TTX, which could be prevented by low concentrations of TTX or saxitoxin. This decrease was due to a reduction in the total number of binding sites and not to a decrease in toxin binding affinities....Continue Reading

References

Mar 3, 1975·Biochemical and Biophysical Research Communications·Y ChaoM A Raftery
Feb 27, 1973·Biochimica Et Biophysica Acta·F V BarnolaG Camejo
Dec 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·T I Benzer, M A Raftery
Oct 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·R HendersonG R Strichartz
Jun 1, 1973·The Journal of General Physiology·A M Woodhull
Oct 17, 1972·Biochemical and Biophysical Research Communications·J Schmidt, M A Raftery
Dec 1, 1972·The Journal of Physiology·D ColquhounJ M Ritchie
Apr 1, 1973·Analytical Biochemistry·J Schmidt, M A Raftery
Apr 16, 1973·Biochemical and Biophysical Research Communications·T I Benzer, M A Raftery
Feb 4, 1974·Biochemical and Biophysical Research Communications·J D Rawn, G E Lienhard
Jan 1, 1970·Progress in Biophysics and Molecular Biology·B Hille
Jun 1, 1972·The Journal of General Physiology·B Hille
May 9, 1972·Biochimica Et Biophysica Acta·D R Hafemann
Dec 1, 1971·The Journal of General Physiology·B Hille
Aug 11, 1970·Biochemical and Biophysical Research Communications·H NakayamaY Kanaoka
Feb 1, 1968·The Journal of General Physiology·B Hille
Oct 1, 1965·The Journal of Physiology·W K Chandler, H Meves
May 1, 1967·The Journal of General Physiology·J W MooreT Narahashi
Feb 27, 1953·The Journal of Physiology·R D KEYNES, H MARTINS-FERREIRA
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Mar 1, 1962·Biophysical Journal·G EISENMAN
Aug 28, 1959·Annals of the New York Academy of Sciences·E SCHOFFENIELS
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY

❮ Previous
Next ❯

Citations

Dec 29, 1977·Molecular and Cellular Biochemistry·F Hucho, W Schiebler
Dec 1, 1991·Pflügers Archiv : European journal of physiology·G Hansen, W Ulbricht
Aug 1, 1990·Pflügers Archiv : European journal of physiology·U LönnendonkerR Stämpfli
Jan 1, 1985·Pflügers Archiv : European journal of physiology·K M Gülden, W Vogel
Dec 1, 1981·Cellular and Molecular Neurobiology·G B Brown, J W Daly
Nov 30, 1979·The Journal of Membrane Biology·B K KruegerM P Blaustein
Jan 1, 1993·Molecular Neurobiology·R G KallenR L Barchi
Jun 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·G R StrichartzJ A Debin
Jan 1, 1983·Progress in Neurobiology·J J McArdle
Jan 1, 1985·Progress in Neurobiology·D Yamamoto
Apr 25, 2000·Toxicon : Official Journal of the International Society on Toxinology·G J DoucetteS G McClain
Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W A CatterallC S Morrow
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W S AgnewM A Raftery
Feb 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R B RogartJ B Galper
May 1, 1993·The Journal of General Physiology·S C Dudley, C M Baumgarten
Nov 1, 1984·The Journal of General Physiology·E MoczydlowskiC Miller
Apr 15, 2010·Marine Drugs·Harry A Fozzard, Gregory M Lipkind
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sebastian K G MaierWilliam A Catterall
Jan 1, 1986·Membrane Biochemistry·A Uehara, E Moczydlowski
May 12, 2009·Journal of Molecular and Cellular Cardiology·Susann G KaufmannSebastian K G Maier
Sep 7, 1976·Biochemical and Biophysical Research Communications·C Palfrey, U Z Littauer
Apr 21, 1984·Journal of Theoretical Biology·G Matsumoto
Jan 1, 1981·Archives of Biochemistry and Biophysics·H H GrünhagenP Reiter
Apr 9, 2005·IEEE Transactions on Nanobioscience·Robert J French, Gerald W Zamponi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.